{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Stephaniae tetrandrae radix", "alkaloid", "cholinesterase", "fangchinoline"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33327436", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "12", "Day": "14"}], "Language": ["eng"], "ELocationID": ["5914", "10.3390/molecules25245914"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "24", "PubDate": {"Year": "2020", "Month": "Dec", "Day": "14"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "The Cholinesterase Inhibitory Properties of Stephaniae Tetrandrae Radix.", "Abstract": {"AbstractText": ["Stephaniae tetrandrae radix (STR) is a commonly used traditional Chinese medicine in alleviating edema by inducing diuresis. In the clinic, STR extracts or its components are widely used in the treatment of edema, dysuria, and rheumatism for the regulation of water metabolism. Furthermore, STR has been used in treating emotional problems for years by combining with other Chinese herbs. However, the material basis and mechanism of STR on the nervous system have not been revealed. Here, the main components of STR extracts with different extracting solvents were identified, including three major alkaloids, i.e., cyclanoline, fangchinoline, and tetrandrine. The cholinesterase inhibitory activity of STR extracts and its alkaloids was determined using the Ellman assay. Both cyclanoline and fangchinoline showed acetylcholinesterase (AChE) inhibitory activity, demonstrating noncompetitive enzyme inhibition. In contrast, tetrandrine did not show enzymatic inhibition. The synergism of STR alkaloids with huperzine A or donepezil was calculated by the median-effect principle. The drug combination of fangchinoline-huperzine A or donepezil synergistically inhibited AChE, having a combination index (CI) < 1 at <i>F<sub>a</sub></i> = 0.5. Furthermore, the molecular docking results showed that fangchinoline bound with AChE residues in the peripheral anionic site, and cyclanoline bound with AChE residues in the peripheral anionic site, anionic site, and catalytic site. In parallel, cyclanoline bound with butyrylcholinesterase (BChE) residues in the anionic site, catalytic site, and aromatic site. The results support that fangchinoline and cyclanoline, alkaloids derived from STR, could account for the anti-AChE function of STR. Thus, STR extract or its alkaloids may potentially be developed as a therapeutic strategy for Alzheimer's patients."]}, "AuthorList": [{"Identifier": ["0000-0003-2013-1131"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical & Food Engineering, Chinese Medicine Master Studio of Wang Shimin, Shanxi University of Chinese Medicine, 121 Daxue Road, Yuci District, Jinzhong 030619, China."}, {"Identifier": [], "Affiliation": "Shenzhen Key Laboratory of Edible and Medicinal Bioresources, HKUST Shenzhen Research Institute, Hi-Tech Park, Shenzhen 518057, China."}], "LastName": "Kong", "ForeName": "Xiang-Peng", "Initials": "XP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shenzhen Key Laboratory of Edible and Medicinal Bioresources, HKUST Shenzhen Research Institute, Hi-Tech Park, Shenzhen 518057, China."}, {"Identifier": [], "Affiliation": "Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China."}], "LastName": "Ren", "ForeName": "Hai-Qin", "Initials": "HQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Food Quality and Safety of Guangdong Province, College of Food Science, South China Agricultural University, Guangzhou 510642, China."}], "LastName": "Liu", "ForeName": "Etta Y L", "Initials": "EYL"}, {"Identifier": ["0000-0002-6137-3877"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shenzhen Key Laboratory of Edible and Medicinal Bioresources, HKUST Shenzhen Research Institute, Hi-Tech Park, Shenzhen 518057, China."}, {"Identifier": [], "Affiliation": "Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China."}], "LastName": "Leung", "ForeName": "Ka-Wing", "Initials": "KW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shenzhen Key Laboratory of Edible and Medicinal Bioresources, HKUST Shenzhen Research Institute, Hi-Tech Park, Shenzhen 518057, China."}, {"Identifier": [], "Affiliation": "Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China."}], "LastName": "Guo", "ForeName": "Shu-Chen", "Initials": "SC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shenzhen Key Laboratory of Edible and Medicinal Bioresources, HKUST Shenzhen Research Institute, Hi-Tech Park, Shenzhen 518057, China."}, {"Identifier": [], "Affiliation": "Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China."}], "LastName": "Duan", "ForeName": "Ran", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shenzhen Key Laboratory of Edible and Medicinal Bioresources, HKUST Shenzhen Research Institute, Hi-Tech Park, Shenzhen 518057, China."}, {"Identifier": [], "Affiliation": "Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China."}], "LastName": "Dong", "ForeName": "Tina T X", "Initials": "TTX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shenzhen Key Laboratory of Edible and Medicinal Bioresources, HKUST Shenzhen Research Institute, Hi-Tech Park, Shenzhen 518057, China."}, {"Identifier": [], "Affiliation": "Division of Life Science and Center for Chinese Medicine, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China."}], "LastName": "Tsim", "ForeName": "Karl W K", "Initials": "KWK"}], "GrantList": [{"GrantID": "2019M653087", "Agency": "China Post-doctoral Science Foundation", "Country": ""}, {"GrantID": "JCYJ20170413173747440; ZDSYS201707281432317; JCYJ20180306174903174", "Agency": "Shenzhen Science and Technology Committee Research Grant", "Country": ""}, {"GrantID": "ZSST20SC03", "Agency": "Zhongshan Municipal Bureau of Science and Technology", "Country": ""}, {"GrantID": "GZSTI16SC02; GZSTI17SC02", "Agency": "Guangzhou Science and Technology Committee Research Grant", "Country": ""}, {"GrantID": "GICI-022", "Agency": "GBA Institute of Collaborate Innovation", "Country": ""}, {"GrantID": "FSUST19-SRI10", "Agency": "Special project of Foshan University of science and technology in 2019", "Country": ""}, {"GrantID": "T13-607/12R", "Agency": "Hong Kong RGC Theme-based Research Scheme", "Country": ""}, {"GrantID": "T13-605/18-W", "Agency": "Hong Kong RGC Theme-based Research Scheme", "Country": ""}, {"GrantID": "UIM/340, UIM/385, ITS/500/18FP; TCPD/17-9", "Agency": "Hong Kong Innovation Technology Fund", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylisoquinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Combinations"}, {"RegistryNumber": "0", "NameOfSubstance": "GPI-Linked Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Solvents"}, {"RegistryNumber": "0111871I23", "NameOfSubstance": "huperzine A"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "18556-27-9", "NameOfSubstance": "cyclanoline"}, {"RegistryNumber": "29EX23D5AJ", "NameOfSubstance": "tetrandrine"}, {"RegistryNumber": "8SSC91326P", "NameOfSubstance": "Donepezil"}, {"RegistryNumber": "953592C3ZB", "NameOfSubstance": "fangchinoline"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "ACHE protein, human"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "BCHE protein, human"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Benzylisoquinolines"}, {"QualifierName": ["analogs & derivatives", "isolation & purification", "pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": [], "DescriptorName": "China"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Donepezil"}, {"QualifierName": [], "DescriptorName": "Drug Combinations"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "GPI-Linked Proteins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}, {"QualifierName": [], "DescriptorName": "Protein Interaction Domains and Motifs"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": ["chemistry"], "DescriptorName": "Solvents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Stephania tetrandra"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wang X.P., Ding H.L. Alzheimer\u2019s disease: Epidemiology, genetics, and beyond. Neurosci. Bull. 2008;24:105\u2013109. doi: 10.1007/s12264-008-0105-7.", "ArticleIdList": ["10.1007/s12264-008-0105-7", "PMC5552509", "18369390"]}, {"Citation": "Giannakopoulos P. Best predictors of cognitive status in AD: Amyloid, neurofibrillary tangles or neuronal loss. Int. Psychogeriatr. 2003;15:192."}, {"Citation": "Reale M., Brenner T., Greig N.H., Inestrosa N., Paleacu D. Neuroinflammation, AD, and dementia. Int. J. Alzheimers Dis. 2010;2010:1340\u20131347. doi: 10.4061/2010/974026.", "ArticleIdList": ["10.4061/2010/974026", "PMC2943141", "20871836"]}, {"Citation": "Checler F., Turner A.J. Journal of Neurochemistry special issue on Alzheimer\u2019s disease: \u2018Amyloid cascade hypothesis-20 years on\u2019. J. Neurochem. 2012;120(Suppl. S1):iii\u2013iv. doi: 10.1111/j.1471-4159.2011.07603.x.", "ArticleIdList": ["10.1111/j.1471-4159.2011.07603.x", "22182264"]}, {"Citation": "Schliebs R., Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer\u2019s disease. J. Neural Transm. (Vienna) 2006;113:1625\u20131644. doi: 10.1007/s00702-006-0579-2.", "ArticleIdList": ["10.1007/s00702-006-0579-2", "17039298"]}, {"Citation": "Levy M.L., Cummings J.L., Kahn-Rose R. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer\u2019s Disease. Gerontology. 1999;45:15\u201322. doi: 10.1159/000052760.", "ArticleIdList": ["10.1159/000052760", "9876214"]}, {"Citation": "Gauthier S., Juby A., Morelli L., Rehel B., Schecter R., ExtendInvestigators A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: The extendstudy. Curr. Med. Res. Opin. 2006;22:2251\u20132265. doi: 10.1185/030079906X132749.", "ArticleIdList": ["10.1185/030079906X132749", "17076986"]}, {"Citation": "Lu P.H., Edland S.D., Teng E., Tingus K., Petersen R.C., Cummings J.L., Alzheimer\u2019s Disease Cooperative Study Group Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 2009;72:2115\u20132121. doi: 10.1212/WNL.0b013e3181aa52d3.", "ArticleIdList": ["10.1212/WNL.0b013e3181aa52d3", "PMC2697965", "19528519"]}, {"Citation": "Digiacomo M., Chen Z., Wang S., Lapucci A., Macchia M., Yang X., Chu J., Han Y., Pi R., Rapposelli S. Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD. Bioorg. Med. Chem. Lett. 2015;25:807\u2013810. doi: 10.1016/j.bmcl.2014.12.084.", "ArticleIdList": ["10.1016/j.bmcl.2014.12.084", "25597007"]}, {"Citation": "Shaddock J.G., Feuers R.J., Chou M.W., Swenson D.H., Casciano D.A. Genotoxicity of tacrine in primary hepatocytes isolated from B6C3F1 mice and aged ad libitum and calorie restricted Fischer 344 rats. Mutat. Res. 1995;344:79\u201388. doi: 10.1016/0165-1218(95)90042-X.", "ArticleIdList": ["10.1016/0165-1218(95)90042-X", "7565897"]}, {"Citation": "Dierckx R.I.R., Vandewoude M.F.J. Donepezil-related toxic hepatitis. Acta Clin. Belg. 2008;63:339\u2013342. doi: 10.1179/acb.2008.066.", "ArticleIdList": ["10.1179/acb.2008.066", "19186568"]}, {"Citation": "Castellino S.M., Tooze J.A., Flowers L., Hill D.F., Mcmullen K.P., Shaw E.G., Parsons S.K. Toxicity and efficacy of the acetylcholinesterase (AChE) inhibitor donepezil in childhood brain tumor survivors: A pilot study. Pediatr. Blood Cancer. 2012;59:540\u2013547. doi: 10.1002/pbc.24078.", "ArticleIdList": ["10.1002/pbc.24078", "PMC3345166", "22238217"]}, {"Citation": "Mishra A., Brinton R.D. Inflammation: Bridging age, menopause and apoe\u03b54 genotype to Alzheimer\u2019s disease. Front. Aging Neurosci. 2018;10:312. doi: 10.3389/fnagi.2018.00312.", "ArticleIdList": ["10.3389/fnagi.2018.00312", "PMC6189518", "30356809"]}, {"Citation": "Gross A.L., Walker K.A., Moghekar A.R., Pettigrew C., Soldan A., Albert M.S., Walston J.D. Plasma markers of inflammation linked to clinical progression and decline during preclinical AD. Front. Aging Neurosci. 2019;11:229. doi: 10.3389/fnagi.2019.00229.", "ArticleIdList": ["10.3389/fnagi.2019.00229", "PMC6742958", "31555121"]}, {"Citation": "Chou R.C., Kane M., Ghimire S., Gautam S., Gui J. Treatment for rheumatoid arthritis and risk of Alzheimer\u2019s disease: A nested case-control analysis. CNS Drugs. 2016;30:1111\u20131120. doi: 10.1007/s40263-016-0374-z.", "ArticleIdList": ["10.1007/s40263-016-0374-z", "PMC5585782", "27470609"]}, {"Citation": "Huang L.-C., Chang Y.-H., Yang Y.-H. Can disease-modifying anti-rheumatic drugs reduce the risk of developing dementia in patients with rheumatoid arthritis. Neurother. J. Am. Soc. Exp. Neurother. 2019;16:703\u2013709. doi: 10.1007/s13311-019-00715-6.", "ArticleIdList": ["10.1007/s13311-019-00715-6", "PMC6694355", "30945124"]}, {"Citation": "Cuya T., Baptista L., Celmar Costa Fran\u00e7a T. A molecular dynamics study of components of the ginger (Zingiber officinale) extract inside human acetylcholinesterase: Implications for Alzheimer disease. J. Biomol. Struct. Dyn. 2018;36:3843\u20133855. doi: 10.1080/07391102.2017.1401004.", "ArticleIdList": ["10.1080/07391102.2017.1401004", "29096599"]}, {"Citation": "Tian F., Xu H. Effect of Huanglian Jiedu Decoction combined with leflunomide on the levels of IL-1\u03b2 and TNF-\u03b1 in serum of patients with rheumatoid arthritis. Shaanxi J. Tradit. Chin. Med. 2017;038:1229\u20131231."}, {"Citation": "Rungsaeng P., Sangvanich P., Karnchanatat A. Zingipain, a ginger protease with acetylcholinesterase inhibitory activity. Appl. Biochem. Biotechnol. 2013;170:934\u2013950. doi: 10.1007/s12010-013-0243-x.", "ArticleIdList": ["10.1007/s12010-013-0243-x", "23625608"]}, {"Citation": "Sun Z.K., Yang H.Q., Chen S.D. Traditional Chinese medicine: A promising candidate for the treatment of Alzheimer\u2019s disease. Transl. Neurodegener. 2013;2:6. doi: 10.1186/2047-9158-2-6.", "ArticleIdList": ["10.1186/2047-9158-2-6", "PMC3599149", "23445907"]}, {"Citation": "Shan L., Tong L., Hang L., Fan H. Fangchinoline supplementation attenuates inflammatory markers in experimental rheumatoid arthritis-induced rats. Biomed. Pharmacother. 2019;111:142\u2013150. doi: 10.1016/j.biopha.2018.12.043.", "ArticleIdList": ["10.1016/j.biopha.2018.12.043", "30579253"]}, {"Citation": "Kong X.P., Liu E., Chen Z.C., Xu M.L., Yu A., Wu Q.Y., Xia Y.J., Duan R., Dong T., Tsim K. Synergistic inhibition of acetylcholinesterase by alkaloids derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex. Molecules. 2019;24:4567. doi: 10.3390/molecules24244567.", "ArticleIdList": ["10.3390/molecules24244567", "PMC6943709", "31847089"]}, {"Citation": "Lv Y.L., Wu Z.Z., Chen L.X., Wu B.X., Chen L.L., Qin G.C., Gui B., Zhou J.Y. Neuroprotective effects of tetrandrine against vascular dementia. Neural Regen. Res. 2016;11:454\u2013459.", "ArticleIdList": ["PMC4829011", "27127485"]}, {"Citation": "Bao F., Tao L., Zhang H. Neuroprotective effect of natural alkaloid fangchinoline against oxidative glutamate toxicity: Involvement of Keap1-Nrf2 axis regulation. Cell. Mol. Neurobiol. 2019;39:1177\u20131186. doi: 10.1007/s10571-019-00711-6.", "ArticleIdList": ["10.1007/s10571-019-00711-6", "31270710"]}, {"Citation": "Koh S.B., Ban J.Y., Lee B.Y., Seong Y.H. Protective effects of fangchinoline and tetrandrine on hydrogen peroxide-induced oxidative neuronal cell damage in cultured rat cerebellar granule cells. Planta Med. 2003;69:506\u2013512.", "ArticleIdList": ["12865967"]}, {"Citation": "Chalupova K., Korabecny J., Bartolini M., Monti B., Lamba D., Caliandro R., Pesaresi A., Brazzolotto X., Gastellier A.J., Nachon F., et al. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer\u2019s disease. Eur. J. Med. Chem. 2019;168:491\u2013514. doi: 10.1016/j.ejmech.2019.02.021.", "ArticleIdList": ["10.1016/j.ejmech.2019.02.021", "30851693"]}, {"Citation": "Marakovi\u0107 N., Kne\u017eevi\u0107 A., Vinkovi\u0107 V., Kovarik Z., \u0160inko G. Design and synthesis of N-substituted-2-hydroxyiminoacetamides and interactions with cholinesterases. Chem. Biol. Interact. 2016;259:122\u2013132. doi: 10.1016/j.cbi.2016.05.035.", "ArticleIdList": ["10.1016/j.cbi.2016.05.035", "27238725"]}, {"Citation": "Giacobini E. Cholinesterases: New roles in brain function and in Alzheimer\u2019s Disease. Neurochem. Res. 2003;28:515\u2013522. doi: 10.1023/A:1022869222652.", "ArticleIdList": ["10.1023/A:1022869222652", "12675140"]}, {"Citation": "Xiong X.J. Fangji Dihuang decoction formula syndrome and Fengyin decoction formula syndrome: Application in stroke and mental disorders. Chin. J. Chin. Mater. Med. 2019;44:602\u2013607.", "ArticleIdList": ["30989929"]}, {"Citation": "Wang Q.S., Ding S.L., Mao H.P., Cui Y.L., Qi X.J. Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice. J. Ethnopharmacol. 2013;148:603\u2013609. doi: 10.1016/j.jep.2013.05.011.", "ArticleIdList": ["10.1016/j.jep.2013.05.011", "23702040"]}, {"Citation": "Ellman G.L., Courtney K.D., Andres V.J., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88\u201395. doi: 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}, {"Citation": "Tsim K.W., Randall W.R., Barnard E.A. An asymmetric form of muscle acetylcholinesterase contains three subunit types and two enzymic activities in one molecule. Proc. Natl. Acad. Sci. USA. 1988;85:1262\u20131266. doi: 10.1073/pnas.85.4.1262.", "ArticleIdList": ["10.1073/pnas.85.4.1262", "PMC279747", "3422489"]}, {"Citation": "Chou T.C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440\u2013446. doi: 10.1158/0008-5472.CAN-09-1947.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-1947", "20068163"]}, {"Citation": "Mak S., Luk W.W., Cui W., Hu S., Tsim K.W., Han Y. Synergistic inhibition on acetylcholinesterase by the combination of berberine and palmatine originally isolated from Chinese medicinal herbs. J. Mol. Neurosci. 2014;53:511\u2013516. doi: 10.1007/s12031-014-0288-5.", "ArticleIdList": ["10.1007/s12031-014-0288-5", "24793543"]}, {"Citation": "Cheung J., Rudolph M.J., Burshteyn F., Cassidy M.S., Gary E.N., Love J., Franklin M.C., Height J.J. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J. Med. Chem. 2012;55:10282\u201310286. doi: 10.1021/jm300871x.", "ArticleIdList": ["10.1021/jm300871x", "23035744"]}, {"Citation": "Nachon F., Carletti E., Ronco C., Trovaslet M., Nicolet Y., Jean L., Renard P.Y. Crystal structures of human cholinesterases in complex with huprine W and tacrine: Elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl- and butyryl-cholinesterase. Biochem. J. 2013;453:393\u2013399. doi: 10.1042/BJ20130013.", "ArticleIdList": ["10.1042/BJ20130013", "23679855"]}, {"Citation": "Vilar S., Cozza G., Moro S. Medicinal chemistry and the molecular operating environment (MOE): Application of QSAR and molecular docking to drug discovery. Curr. Top. Med. Chem. 2008;8:1555\u20131572. doi: 10.2174/156802608786786624.", "ArticleIdList": ["10.2174/156802608786786624", "19075767"]}, {"Citation": "Ikemura N., Yamaori S., Kobayashi C., Kamijo S., Murayama N., Yamazaki H., Ohmori S. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine. Chem. Biol. Interact. 2019;306:1\u20139. doi: 10.1016/j.cbi.2019.04.005.", "ArticleIdList": ["10.1016/j.cbi.2019.04.005", "30965050"]}, {"Citation": "Al-Shamary D.S., Al-Alshaikh M.A., Kheder N.A., Mabkhot Y.N., Badshah S.L. Molecular docking and biological evaluation of some thioxoquinazolin-4(3H)-one derivatives as anticancer, antioxidant and anticonvulsant agents. Chem. Cent. J. 2017;11:48. doi: 10.1186/s13065-017-0272-6.", "ArticleIdList": ["10.1186/s13065-017-0272-6", "PMC5451370", "29086826"]}, {"Citation": "Tang Q.Y., Zhang C.X. Data Processing System (DPS) software with experimental design, statistical analysis and data mining developed for use in entomological research. Insect Sci. 2013;20:254\u2013260. doi: 10.1111/j.1744-7917.2012.01519.x.", "ArticleIdList": ["10.1111/j.1744-7917.2012.01519.x", "23955865"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "2"}, {"Year": "2020", "Month": "12", "Day": "8"}, {"Year": "2020", "Month": "12", "Day": "10"}, {"Year": "2020", "Month": "12", "Day": "17", "Hour": "1", "Minute": "2"}, {"Year": "2020", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["33327436", "PMC7764916", "10.3390/molecules25245914", "molecules25245914"]}}], "PubmedBookArticle": []}